当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3519798
已选条件
-
T21402LRemimazolam Tosilate(308242-62-8 Free base)甲苯磺酸瑞马唑仑;CNS-7056
Remimazolam Tosilate is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.
价 格:¥电议型 号:T21402L产 地:中国大陆
-
T0117Suplatast (Tosilate)IPD 1151T;Suplatast tosilate;Suplatast Tosylate;甲磺司特
Suplatast Tosilate is a novel capsular anti-asthmatic drug. It ( IC50 above 100 μM) inhibits both IgE production, IL-4 and IL-5 synthesis.
价 格:¥电议型 号:T0117产 地:中国大陆
-
T0078LLapatinib ditosylateLapatinib tosilate;Lapatinib ditosylate monohydrate;Tyverb;Tykerb;Lapatinib dito
Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent ac
价 格:¥电议型 号:T0078L产 地:中国大陆
-
T0078LLapatinib ditosylate monohydrateLapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohy
Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent ac
价 格:¥电议型 号:T0078L产 地:美洲
-
T0117Suplatast tosilateSuplatast tosilate,IPD 1151T,Suplatast Tosylate
Suplatast Tosilate is a novel capsular anti-asthmatic drug. It ( IC50 above 100 μM) inhibits both IgE production, IL-4 and IL-5 synthesis.
价 格:¥电议型 号:T0117产 地:美洲
-
T3522Tosufloxacin tosilate;甲苯磺酸妥舒沙星Tosufloxacin tosilate
Tosufloxacin tosilate is a fluoroquinolone antibiotic.
价 格:¥电议型 号:T3522产 地:中国大陆
-
T0117Suplatast (Tosilate);甲磺司特IPD 1151T|||Suplatast tosilate|||Suplatast Tosylate;IPD 1151T|||甲磺司特|||Supl
Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug. It ( IC50 above 100 μM) inhibits both IgE production, IL-4 and IL-5 synthesis.
价 格:¥电议型 号:T0117产 地:中国大陆